21st Century Oncology Inc:企業の戦略的SWOT分析

◆英語タイトル:21st Century Oncology Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C15786
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

21st Century Oncology Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

21st Century Oncology Inc (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services. It provides radiation therapy and integrated cancer care services to patients. The company has affiliations with physicians specializing in the areas of medical oncology, urology, gynecological, breast and surgical oncology, general surgery, radiation oncology, and primary care. It also offers specialized delivery systems for internal beam radiation therapy. The company operates through international treatment centers operations in the US and in certain Latin American markets. 21st Century Oncology is headquartered in Fort Myers, Florida, the US.

21st Century Oncology Inc Key Recent Developments

Mar 14,2019 21st Century Oncology bolsters its best-in-class Oncology dream team by adding five nationally renowned physicians
Jan 07,2019 21st Century Oncology hires Powell as chief operating officer
Apr 18,2018 21st Century Oncology Names Kimberly Commins-Tzoumakas As Chief Executive Officer

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
21st Century Oncology Inc – Key Facts
21st Century Oncology Inc – Key Employees
21st Century Oncology Inc – Key Employee Biographies
21st Century Oncology Inc – Major Products and Services
21st Century Oncology Inc – History
21st Century Oncology Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
21st Century Oncology Inc – Business Description
21st Century Oncology Inc – SWOT Analysis
SWOT Analysis – Overview
21st Century Oncology Inc – Strengths
21st Century Oncology Inc – Weaknesses
21st Century Oncology Inc – Opportunities
21st Century Oncology Inc – Threats
21st Century Oncology Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
21st Century Oncology Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 14, 2019: 21st Century Oncology bolsters its best-in-class Oncology dream team by adding five nationally renowned physicians
Jan 07, 2019: 21st Century Oncology hires Powell as chief operating officer
Apr 18, 2018: 21st Century Oncology Names Kimberly Commins-Tzoumakas As Chief Executive Officer
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
21st Century Oncology Inc, Key Facts
21st Century Oncology Inc, Key Employees
21st Century Oncology Inc, Key Employee Biographies
21st Century Oncology Inc, Major Products and Services
21st Century Oncology Inc, History
21st Century Oncology Inc, Other Locations
21st Century Oncology Inc, Subsidiaries
21st Century Oncology Inc, Key Competitors
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
21st Century Oncology Inc, Recent Deals Summary

List of Figures
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[21st Century Oncology Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hafslund ASA:企業の戦略的SWOT分析
    Hafslund ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • China National Materials Co Ltd:企業の戦略・SWOT・財務情報
    China National Materials Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China National Materials Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Sungrow Power Supply Co Ltd (300274):企業の財務・戦略的SWOT分析
    Summary Sungrow Power Supply Co Ltd (Sungrow) is a renewable energy company that manufactures power supply equipment for solar PV (photovoltaic) and wind power projects. The company's products include PV inverters, floating systems, storage systems and accessories. It offers services such as constru …
  • Tempo Beverages Ltd.:企業の戦略・SWOT・財務情報
    Tempo Beverages Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tempo Beverages Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • BioNTech AG:製薬・医療:M&Aディール及び事業提携情報
    Summary BioNTech AG (BioNTech) is a biopharmaceutical company that develops biomarker based diagnostics. The company’s products include RNXtract and mammatyper, and cell and gene therapies. It pipeline products include BioNTech mRNA pharmaceuticals, BioNTech cell and gene, BioNTech small molecules a …
  • J.B. Hunt Transport Services, Inc.:企業の戦略・SWOT・財務分析
    J.B. Hunt Transport Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary J.B. Hunt Transport Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Mastech Digital Inc (MHH):企業の財務・戦略的SWOT分析
    Summary Mastech Digital Inc (Mastech) operates as an IT staffing company that offers digital transformation services. The company offers services such as database administration, middleware, business analytics and QA, data warehousing, admin desktop fiac, and project management services, among other …
  • Repsol, S.A.:企業の戦略・SWOT・財務分析
    Repsol, S.A. - Strategy, SWOT and Corporate Finance Report Summary Repsol, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Albumedix AS-製薬・医療分野:企業M&A・提携分析
    Summary Albumedix A/S (Albumedix), a subsidiary of Novozymes A/S, is a developer of albumin-based products and technologies for advanced drug and vaccine formulation, extended drug half-life and improved drug delivery. Its product Recombumin is a recombinant human albumin used in the manufacture of …
  • Immunicum AB (IMMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that focuses on the development of immuno-oncology therapies for the treatment of solid tumors. The company’s lead development candidate, ilixadencel is in clinical trials for the treatment a range of solid tumors including hepatic cell …
  • VAMED AG:企業の戦略・SWOT・財務情報
    VAMED AG - Strategy, SWOT and Corporate Finance Report Summary VAMED AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Arafura Resources Ltd:企業の戦略・SWOT・財務分析
    Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Breakthru Beverage Group, LLC:企業の戦略・SWOT・財務分析
    Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report Summary Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Ctrip.com International, Ltd.:企業の戦略・SWOT・財務情報
    Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • J.W. Ostendorf Gmbh & Co Kg:企業の戦略・SWOT・財務分析
    J.W. Ostendorf Gmbh & Co Kg - Strategy, SWOT and Corporate Finance Report Summary J.W. Ostendorf Gmbh & Co Kg - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Covanta Holding Corp (CVA):企業の財務・戦略的SWOT分析
    Covanta Holding Corp (CVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • EryDel SPA:製薬・医療:M&Aディール及び事業提携情報
    Summary EryDel SPA (EryDel), a subsidiary of Genextra Spa is a drug delivery company that develops drugs and diagnostics delivered through human red blood cells using a proprietary medical device technology. The company’s products include red cell loaders, and disposable kits for drug encapsulation …
  • Davide Campari-Milano S.p.A.:戦略・SWOT・企業財務分析
    Davide Campari-Milano S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Davide Campari-Milano S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Dentsply Sirona Inc (XRAY):企業の財務・戦略的SWOT分析
    Dentsply Sirona Inc (XRAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • curasan AG (CUR):製薬・医療:M&Aディール及び事業提携情報
    Summary curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, ora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆